KETOROLAC Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

KETOROLAC Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses

Ketorolac

IUPAC nomenclature

(±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid

Classification

  • NSAID
  • Propionic acid class

 

Physiochemical Properties

S. NO. PHYSICAL AND CHEMICAL PROPERTIES
1 Molecular weight 255.27 g/mol
2 Physical appearance Solid
3 Melting point 162-165°C
4 Solubility Trimethamine salt solubility is 200 g/L
5 Octanol/water partition coefficient 2.1
6 Presence of ring Pyrrolizine, phenyl
7 Number of chiral centers 1

 

Mechanism of Action

  • Ketorolac non-selectively inhibits COX-1 and COX-2 enzymes which are responsible for the synthesis of prostaglandins.
  • The reduced level of prostaglandins responsible for controlling the inflammation and pain in the body.

 

Structure Activity Relationship

SAR of propionic acid derivatives can be summarized as follows:

  • Anti-inflammatory activity of the drug can be increased by substitution of an α-methyl group on the alkanoic acid portion of acetic acid derivatives.
  • Related side effects of the drug can be decreased by substitution of an α-methyl group on the alkanoic acid portion of acetic acid derivatives.
  • S- (+)-enantiomer possess greater activity than (-)-enantiomer.[1]

 

Method of synthesis

i. (STEP I): Pyrrole is converted into pyrrole Grignard reagent by the reaction of pyrrole with methylmagnesium chloride.

ii. (STEP 2): Pyrrole Grignard reagent so formed is contacted with dihalobutanamide to form N-alkyl-N-aryl-4-chloro-2-(2-pyrrolyl)butanamide.

iii. (STEP 3): The pyrrolylbutanamide is cyclized to form N-alkyl-N-aryl-2,3-dihydro-1H-pyrrolizine-1-carboxamide.

iv. (STEP 4): The above formed compound undergoes 5-aroylation method to form N-alkyl-N-aryl-5-benzoyl-2,3-dihydro-1H pyrrolizine-1-carboxamides.

v. (STEP 5): The ketorolac-amide so formed is converted to ketorolac through hydrolysis using strong base in an alkanol. [2]

Therapeutic Uses

Ketorolac is used for:

  • Short-term treatment for moderate to severe pain
  • Used before or after medical surgery for reducing the pain 

 

Side Effects

Side effects of Ketorolac are:

  • Skin rash
  • Changes in vision
  • Shortness of breath
  • Weight gain
  • Swelling
  • Stomach bleeding
  • Nausea
  • Jaundice
  • Pale skin
  • Difficulty in urination
  • Anemia
  • Skin reactions
  • Indigestion
  • Nausea
  • Vomiting
  • Tremors
  • Stomach pain
  • Confusion
  • Diarrhea
  • Constipation
  • Drowsiness
  • Dizziness
  • Headache
  • Sweating
  • Symptoms of meningitis

 

MCQs

Q.1 “(±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid” is the IUPAC nomenclature of which drug?

a) Ketorolac

b) Pralidoxim

c) Morphine

d) Scopolamine

Q.2 Melting point of ketorolac is?

a) 163oC

b) 163K

c) 163oF

d) None of the above

Q.3 Match the following with correct classifications of the drugs.

i. Ketorolac A. Inhalational anesthetics
ii. Promazine B. Carbamate cholinesterase inhibitor
iii. Halothane C. NSAID
iv. Pyridostigmine D. Phenothiazine

 a) i-A, ii-D, iii-B, iv-C

b) i-D, ii-A, iii-B, iv-C

c) i-D, ii-C, iii-A, iv-B

d) i-C, ii-D, iii-A, iv-B

Q.4 Correct statements from below which are related with the mechanism of action of Ketorolac can be??

I. It is a non-selective COX inhibitor

II. Side effects of drug is due to COX-2 inhibition

III. Therapeutic action is due to COX-1 inhibition

IV. COX inhibition results in reduced production of prostaglandins

a) I ,IV

b) III, II

c) IV , I

d) II , III

Q.5   Correct sequence for True and False for the given statements related with the SAR of propionic acid derivatives can be?

  • Anti-inflammatory activity of the drug can be decreased by substitution of an α-methyl group on the alkanoic acid portion of acetic acid derivatives.
  • Related side effects of the drug can be decreased by substitution of an α-methyl group on the alkanoic acid portion of acetic acid derivatives.
  • S- (+)-enantiomer possess greater activity than (-)-enantiomer

a) TFF

b) FFT

c) FTF

d) FTT

Q.6 Ketorolac-amide can be converted to Ketorolac through?

a) Hydrolysis

b) Alkylation

c) Demethylation

d) Chlorination 

Q.7 The drug ketorolac is mainly used for?

a) Treatment of seizures

b) As an anesthetic

c) Reducing mild to severe pain

d) All of the above

 

For More Standard and Quality Question Bank you can Join Our Test Series Programme for GPAT, NIPER JEE, Pharmacist Recruitment Exam, Drug Inspector Recruitment Exams, PhD Entrance Exam for Pharmacy

Participate in Online FREE  GPAT  TEST: CLICK HERE

  Participate in Online FREE  Pharmacist  TEST: CLICK HERE 

Participate in Online FREE  Drug Inspector  TEST: CLICK HERE 

 

 

ANSWERS

1-a

2-a

3-d

4-a

5-d

6-a

7-c

 

REFERENCES

[1]  Lemke TL, Williams DA, Roche VF, Zito SW. FOYE. S Principles of Medicinal Chemistry. Seventh Edition Copyright. 2013.

[2] Harrington PJ, Khatri HN, Schloemer GC, inventors; Syntex USA LLC, assignee. Preparation of ketorolac. United States patent US 6,197,976. 2001 Mar 6.

×

Developed By Connect Globes